Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis

Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis

(2022) Thomas E. Williams et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation

(2022) Arie R. Gafson et al.   JAMA Network Open

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

(2022) Pascal Benkert et al.   LANCET NEUROLOGY

Blood Neurofilament Light in Progressive Multiple Sclerosis

(2022) David Leppert et al.   NEUROLOGY

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

(2021) José I. Fernández-Velasco et al.   Neurology-Neuroimmunology & Neuroinflammation

Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis

(2021) Robert J Fox et al.   Multiple Sclerosis Journal

Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis

(2021) James Giarraputo et al.   JOURNAL OF NEUROIMMUNOLOGY

The potential of serum neurofilament as biomarker for multiple sclerosis

(2021) Stefan Bittner et al.   BRAIN

Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis

(2021) Simone Guerrieri et al.   Frontiers in Neuroscience

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

(2021) Marcus W. Koch et al.   ANNALS OF NEUROLOGY

Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis

(2021) Heather Y. F. Yong et al.   Nature Reviews Neurology

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

(2020) Elias S. Sotirchos et al.   ANNALS OF NEUROLOGY

Neurofilaments in progressive multiple sclerosis: a systematic review

(2020) Thomas Williams et al.   JOURNAL OF NEUROLOGY

Serum neurofilament light chain and optical coherence tomography measures in MS

(2020) Eleonora Tavazzi et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum neurofilament light as a biomarker in progressive multiple sclerosis

(2020) Raju Kapoor et al.   NEUROLOGY

Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

(2020) Xavier Ayrignac et al.   Scientific Reports

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

(2019) Ahmed Abdelhak et al.   Frontiers in Neurology

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients

(2019) Diana Ferraro et al.   ACTA NEUROLOGICA SCANDINAVICA

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity

(2018) Heidi Högel et al.   Multiple Sclerosis Journal

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

(2016) Elena H Martinez-Lapiscina et al.   LANCET NEUROLOGY

Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis

(2015) Marcus W. Koch et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes

(2012) Jeffrey M. Gelfand et al.   PLoS One

Using retinal architecture to help characterize multiple sclerosis patients

(2010) Fiona Costello et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY